GENESIS Biomed, a consulting company specialized in R + D projects in biomedicine, has recently established its Business Advisory Board, a multidisciplinary panel of experts, KOL in their respective s...
In 2020, AFB started its early-stage investment strategy in Spain by investing in ARTHex Biotech, a preclinical stage life sciences company focused on the development of the next generation antisense ...
Según el acuerdo suscrito el inversor se ha comprometido a invertir, de forma regular en la Sociedad, y a solicitud de ADL Bionatur, hasta un importe máximo de 5.000.000 euros mediante el desembolso...
The main source of this funding was venture capital, with a total of €140 million. There were 41 operations in total, up 58% from 2019. This data is from the final version of the “Investment in St...
Aura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the closing of an oversubsc...
Gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by LAVA, are expected to be $100.5 million. The offering is expected to clos...
The company announces a €14.35M Series A, one of the biggest rounds in the Spanish medtech industry, co-led by Asabys Partners and Alta Life Sciences, joined by CDTI Innvierte and two international ...
Lanzadera, la aceleradora de empresas impulsada por Juan Roig, ha desarrollado el Hub de Innovación en Salud, una iniciativa que agrupará en Marina de Empresa a grandes corporaciones, empresas tecno...
Talde Promoción y Desarrollo SCR, S.A. and Kaizaharra Corporación Empresarial (KCE) have entered AJL OPHTALMIC`, S.A.’s shareholding structure, a basque company based in Alava, dedicated to the de...
Vivet’s second gene therapy product, VTX-803 for PFIC3, received US and European Orphan Drug Designation in May 2020.Vivet is supported by international life science investors including Novartis Ven...
During Q1 2021, Aurora I has continued investing in top global players, in both the ICT and Life Sciences sectors. During the quarter, the Fund of Funds has committed to 6 additional funds, taking the...
Synendos Therapeutics (Synendos), a biopharmaceutical company focused on restoring the natural functioning of the endocannabinoid system to treat Central Nervous System (CNS) disorders, announces an e...